A step closer to multi-cancer early diagnosis availability for patients in low- and middle-income countries Please note that the full article was originally published in Health Management Journal Volume 23 – Issue 3 The scale of destruction wreaked on human life...
The patient perspective on pharmaceutical expanded access programmes (EAPs) Introduction Pharmaceutical expanded access programmes (EAPs), also referred to as “compassionate use” programmes, are designed to provide later-stage patients with access to new...
We are on a mission to inspire and empower patients, researchers and clinicians to work together to prevent, treat and eliminate cancer. We are honoured that Professor Friend is one of our ambassadors. He has been a good relation and advisor for Inspire2Live since the...
Watch this presentation and discussion with Audrey Coiffic, PHD, Engagement Manager at IQVIA France on How to accelerate implementation of precision oncology in Low and Middle Income Countries (LIMC). Audrey Coiffic on How to accelerate implementation of precision...
When done by the right organisation in the right way, we can learn a lot about individual cancer cases via molecular diagnostics which helps us to find out exactly what is going on for each individual patient. The whole world talks about personalised medicine but when...
